Analyst Reco. Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Market Closed - Nasdaq Other stock markets 01:30:00 02/05/2024 am IST			5-day change	1st Jan Change
3.96 ^USD	+3.66%		+3.94%	-18.85%

05/04	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	CI
06/03	JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	06/03	MT
UBS Adjusts Akoya Biosciences Price Target to $7.50 From $7, Maintains Buy Rating	05/03	MT
Stephens Adjusts Price Target on Akoya Biosciences to $9 From $14, Maintains Overweight Rating	13/11	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $8 From $15, Keeps Overweight Rating	24/23/24	MT
UBS Cuts Akoya Biosciences Price Target to $7 From $12, Maintains Buy Rating	12/23/12	MT
UBS Adjusts Akoya Biosciences Price Target to $12 From $13, Maintains Buy Rating	08/23/08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $15 From $16, Maintains Overweight Rating	08/23/08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $16 From $17, Maintains Overweight Rating	10/23/10	MT
UBS Adjusts Akoya Biosciences Price Target to $13 From $14, Maintains Buy Rating	09/23/09	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $17 From $18, Maintains Overweight Rating	08/23/08	MT
UBS Initiates Coverage on Akoya Biosciences With Buy Rating, $14 Price Target	02/23/02	MT
Capital One Initiates Akoya Biosciences at Overweight Rating With $19 Price Target	03/22/03	MT
Stephens Starts Akoya Biosciences at Overweight With $16 Price Target	06/22/06	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $17 From $14, Reiterates Overweight Rating	18/22/18	MT
BTIG Starts Akoya Biosciences at Buy With $16 Price Target	22/22/22	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $14 From $18, Reiterates Overweight Rating	16/22/16	MT
Morgan Stanley Trims Akoya Biosciences Price Target to $18 From $19, Maintains Overweight Rating	09/22/09	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $18 From $23, Reiterates Overweight Rating	18/22/18	MT
JPMorgan Adjusts Akoya Biosciences' Price Target to $20 from $25, Keeps Overweight Rating	15/22/15	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $19 from $20, Keeps Overweight Rating	15/22/15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Analyst Reco.

Filters